Speaker Bio's

Speaker Times

January 10th, 2012

Free TTC User Workshop: 8:30-10:00 - Interact with TTC staff on various topics

Dean Andrew Peterson: 10:00-10:15 - Welcoming Comments

Dr. John Hubbard :10:15-11:00 - Current Industry Practices

Dr. Harold Glass: 11:00-12:00 - What does Cost Data tell us about the State of Drug Development

Dr. Larry Poli: 1:30-2:30    - Panel discussion The Value of Cost Data to Upper Management

Ying Jiang: 2:30-3:30                  - Panel discussion Working with Countries that are Difficult to Budget and Negotiate

Holly Squires: 3:45-4:45             - Panel discussion Standard of Care - Trends and Case Studies

Dr. Harold Glass: 4:45-5:00       - Wrap up comments

January 11th, 2012

Free USciences Student Panel Discussion: 8:30-9:30 - Career Oppertunities in Pharmaceutical and CRO Companies

Dr. Harold Glass: 10:00-10:15 - Welcoming Comments

Dr. Peter Aurup: 10:15-11:15 - Future Challenges for Big Pharma

Dr. Larry Poli: 11:15-12:15           - Panel discussion Late Phase Study Planning and Budgeting

Break-Out Round Table Discussion: 1:30-2:15 - Finance; Site Start-Up and Clinical Operations; and Compliance

Dr. Douglas Peddicord: 2:15-2:45 - CROs in Today's Drug Development

Dr. Larry Poli: 2:45-3:30               - Panel discussion CRO's

Dr. Harold Glass: 3:30-3:45     - Wrap-up Presentation

Dr. Peter Aurup
Peter Aurup, M.D., is Head of Global Clinical Trial Operations (GCTO) at Merck Research Laboratories. In this role, he is responsible for all aspects of clinical trial execution including data management for all phases of global, regional and local studies. Dr. Aurup leads 3,800 people in the GCTO, with locations in the U.S. and abroad. Currently, there are approximately 275,000 patients participating in Merck/MSD sponsored clinical trial programs worldwide.
read more

Deirdre BeVard
Deirdre BeVard is Vice President, Development Operations at Endo Pharmaceuticals. In this capacity she is responsible for the operational execution of clinical development of Endo’s pipeline.
read more

Dr. Alan Braverman
Alan J. Braverman, PharmD has 25 + years of experience in clinical drug development and is the former Vice President of North American Operations for PSI, an International CRO. Throughout his career which started as a medical writer at SK&F (now GSK), Alan has held positions in clinical as well as business development for both CRO’s and pharmaceutical companies alike.
read more

Bettye Briggs
Bettye Briggs is currently Associate Director for Global Financial Specialists at Merck Research Laboratories, responsible for the development of clinical trial study budgets for all phases & therapeutic areas for over 60 countries globally assuring that the site budgets reflect the design and requirements of the study, with the appropriate benchmark costs.

read more

Dr. Peter Carberry
Dr Carberry is responsible for enhancing the effectiveness and efficiency of the integrated global operational platform including the data sciences and clinical operations organizations.
read more

Dr. Harold Glass
Dr. Harold Glass has more than twenty years of international experience in business and the pharmaceutical industry. He is a professor of Health Policy at the University of the Sciences in Philadelphia and senior research fellow at the Centre for Evidence Based Policy, Kings College, University of London.
read more

Dr. David Green
David Green Ph.D., Vice President, Transformation and Alliance Management at ReSearch Pharmaceutical Services. At RPS he is responsible to focus on sourcing solution strategies in concert with RPS and Sponsor Executive Management. Dr. Green defines, develops and leads Transformational models and innovative approaches to customer solutions. In addition, he provides high-level executive management governance oversight and support across numerous global key customers.
read more

Anup Kharode
Anup is a Director in the PricewaterhouseCoopers' Pharmaceutical & Life Sciences R&D Advisory Services practice with over twelve years of experience working in the pharmaceutical and life sciences industry focused on R&D.
read more

Dr. John Hubbard
Dr. Hubbard is Senior Vice President and Worldwide Head of Development Operations for Pfizer Inc. In this position, he is responsible for global clinical trial management from Phase I to IV, which includes more than 700 clinical projects across specialty care, primary care, oncology, established products, emerging markets, vaccines business units and pharma- and bio-therapeutic research units.
read more

Ying Jiang
Ying Jiang joined TTC, LLC in 2005. Her rapid climb to the Client Operations Director position resulted from Ying’s expert command of forecasting and budgeting for global clinical trial investigator costs and investigator initiated studies.
read more

Dr. Mitchell Katz
Dr. Mitchell Katz is Executive Director of Medical Research Operations at Purdue Pharma L.P. In this position he is responsible for the direction of all activities within medical research operations across all of Purdue’s clinical programs.
read more

Dr. Michael Lauer
Michael Lauer, M.D., is the director of the Division of Cardiovascular Sciences at the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH). In this position, Dr. Lauer provides leadership for the Institute's national program for research on the causes, prevention, and treatment of cardiovascular (basic, clinical, population, and health sciences) diseases. Dr. Lauer joined the NHLBI in July 2007.
read more

Dr. Fred Naids
Dr. Fred Naids is currently the Senior Strategic Sourcing Director for Shire Pharmaceuticals’ Clinical Development Operations & Biometrics organization. In this role, he is responsible for developing, implementing, and maintaining a global outsourcing strategy that supports all clinical trial activities, from Phase II through Phase IV.
read more

Dr. Douglas Peddicord
Following a career as a clinical psychologist, Doug Peddicord came to Capitol Hill as an American Association for the Advancement of Science (AAAS) Congressional Fellow in 1994. With policy expertise in the conduct and regulatory oversight of clinical trials, Dr. Peddicord serves as Executive Director of the Association of Clinical Research Organizations (ACRO).
read more

Dr. Laurence Poli
Dr. Laurence G. Poli joined TTC, llc in 2008 as Vice President, Business and Product Development after an extensive pharmaceutical marketing and teaching career. Over the past 20 years, he has worked with marketing teams in major pharmaceutical corporations including AstraZeneca, GlaxoSmithKline, Solvay, Merck, Wyeth and Johnson & Johnson, while serving as a sought after lecturer on the future of pharmaceutical marketing in the U.S. healthcare system.
read more

Tom Schaible
Vice President of Medical Affairs, Jannsen Bio pharm at Johnson & Johnson
read more

Ira Spector
Senior Vice President Global Development Operations, Allergan
read more

Holly Squires
Holly Squires is one of the founders of TTC. She worked at DataEdge, Dr. Glass’s first clinical trial cost benchmarking company for five years as manager of client services. After the sale of DataEdge to IMS Health, Holly joined the pharmaceutical company Pharmacia, working in its Global Budgeting/Business Analysis group.
read more

Rehbar Tayyabhan
Reb Tayyabkhan is an Executive Director at Bristol Myers Squibb responsible for the Business Operations function within Global Development Operations. His group is responsible for oversight of resource/portfolio planning, US site contracts, financial mgmt and process improvement.
read more

Kate Tranotti
President of Clinical Operations at ICON Clinical Research for 8 years
read more

Dr. Scott Treiber
Dr. Scott Treiber is currently Senior Vice President at Hospira’s global clinical operations and medical affairs.
read more

Jeff Trotter
Jeff Trotter has enjoyed a varied career in the healthcare industry spanning the past 25 years. As an entrepreneur, researcher, consultant, and industry leader, Jeff has been a pioneer in the evolving health economics and outcomes research community. Jeff was founder and president of Ovation Research Group, one of the leading independent research and consulting organizations providing health economics and outcomes research for pharmaceutical and medical device industry clients.
read more

Kelly Willenberg
Kelly Willenberg is the President of Synergism, LLC. A new approach to healthcare compliance consulting. Kelly approaches clients as "advocates working together". Prior positions include the Director of Billing Compliance and the Director of the Cancer Center's Clinical Trials Office, both at Vanderbilt University Medical Center.
read more

Walter Young
Walter Young is the Strategic Sourcing Director, CDO&B for Shire. Walt is responsible for developing and managing Shire's interactions/relationships with its key strategic services suppliers, specifically those that support Global Clinical Development Operations and Biostatistics Group. He has over 18 years of industry experience in the pharmaceutical and medical diagnostic arenas and has held positions both in the U.S. and the U.K.
read more

Hani Zaki
Hani Zaki is the founder and Managing Director of Clinical Development Outsourcing Strategies™ (www.cdoStrat.com), a consultancy dedicated to best-practices in clinical development outsourcing. Hani provides insight, planning analysis, and strategic direction to Bio-Pharma, CROs, institutions, and investment organizations across the spectrum of the clinical development outsourcing market.
read more

this website built by blue circle designs

Speaker Bio's

Speaker Times

Sponsors

Connect With Us